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1. Introduction 
All proteins in living cells seem to be degraded and 
resynthesized continuously. The rate of this turnover 
depends upon structural features of the protein. Thus 
high turnover tends to correlate with high molecular 
mass, low isoelectric point, and pronounced hydro- 
phobicity [l-3]. Cells can be induced to synthesize 
abnormal proteins by mutations and by addition of 
puromycin or amino acid analogues. Such abnormal 
proteins are generally rapidly degraded within the cell 
[1,21. 
Protein degradation is enhanced during starvation 
and after transition from growth to quiescence. The 
relative enhancement is usually larger for the more 
stable proteins than for those with fast turnover 
[4-81. Furthermore, a reduction in temperature or 
addition of many compounds inhibits the enhanced 
degradation of stable proteins more than that of 
unstable normal or abnormal proteins [5,9-l 11. Such 
observations led to the hypothesis [ 51 that abnormal 
proteins are catabolized by a pathway that is distinct 
from that utilized for enhanced degradation. This sug- 
gestion was questioned in [ 12,131, where puromycinyl- 
peptides were degraded at a much slower rate in grow- 
ing than in non-growing rat liver. 
Here I report that results similar to those in [ 12,131 
can be obtained with cell cultures. However, the dif- 
ference between growing and quiescent cells in degra- 
dation rates of abnormal proteins resides in a differ- 
ence in proteins rather than in the degradative machin- 
ery of the cells. 
2. Materials and methods 
L-[4,5-3H] Leucine was obtained from the Radio- 
ElsevierlNorth-Holland Biomedical Press 
chemical Centre, Amersham. D,Lp-Fluorophenylala- 
nine and puromycin were purchased from Sigma. 
Balb/3T3 cells were grown in Eagle’s MEM with 
Earle’s salts and 10% (v/v) newborn calf serum (Gibco- 
Biocult). Media used for experiments contained peni- 
cillin G (100 IU/ml) and streptomycin sulphate 
(100 pg/ml) and the bicarbonate buffer was substi- 
tuted by 10 mM TES (N-tris-(hydroxymethyl)-methyl- 
2aminoethanesulfonic acid) and 10 mM Hepes 
(N-2-hydroxyethylpiperazine-N’-2ethanesulfonic acid). 
PBS, as used here, refers to a solution containing 
137 mM NaCl, 2.7 mM KCl, 4.1 mM Na&IP04, and 
0.73 mM KHZPOG, pH 7.4. 
All experiments were carried out at 37’C. Data 
relevant for each experiment are given in the figure 
legends. The methods are detailed in [ 81. 
3. Results ani discussion 
The fibroblast cell line used here is subject to 
growth control by serum concentration and culture 
density [ 141. Fig.1 shows, in accord with [8] that pro- 
tein is degraded faster in quiescent cells than in grow- 
ing ones, and that proteins containing puromycin or 
fluorophenylalanine [ 1,2] are more rapidly degraded 
than normal cell proteins. Fig.1 also shows that with 
this experimental protocol quiescent cells degrade 
both normal and abnormal proteins faster than do 
growing cells. 
The difference in degradation rates of abnormal 
proteins between growing and quiescent cells may 
reflect differences in the degradative apparatus, or 
quantitative differences in the effects of puromycin 
and fluorophenylalanine on protein synthesis in the 
two growth states. Indeed, fig.2 shows that protein 
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Fig.1. Degradation of normal cell proteins, abnormal proteins 
containing p-fluorophenylalanine and of puromycin-peptides 
in growing and in density-inhibited Balb/3T3 cells. Growing 
and density-inhibited Balb/3T3 cultures were prepared in 
5 cm Petri dishes as in [ 81. The cultures were incubated for 
30 min in 3 ml of either normal growth medium (0,~) or in 
medium with 5 mM D,L-p-fluorophenylalanme instead of 
phenylalanine (AC) or in medium with puromycin, 20 pg/ml 
(o,m). The medium was then changed to the same medium, 
but with 0.2 mM [ ‘Hlleucine (10 rCi/ml), whereupon the 
cultures were incubated for 1 h. The cultures were then 
washed in 3 X 6 ml PBS with 0.2 mM leucine and added 9 ml 
growth medium with 10% v/v calf serum and 4 mM unlabelled 
leucine. Protein degradation was assessed from the trichloro- 
acetic acid-soluble radioactivity in samples of medium, taken 
of the indicated times [ 81. Open and filled symbols denote 
growing and density-inhibited cultures, respectively. 
synthesis is more sensitive to puromycin in quiescent 
cells than it is in growing cells. Similar results were 
obtained with fluorophenylalanine (not shown). 
Puromycin is a peptidechain terminator, and the 
size of the puromycinyl-peptides decreases with 
increasing concentration of puromycin and, hence 
with increasing inhibition of amino acid incorporation 
[ 151. Among puromycinyl-peptides, those with low 
molecular mass are the least stable [ 161. The metab- 
olic stability of puromycinyl-peptides is therefore 
also correlated to the inhibition of amino acid incor- 
poration, as shown in fig.3. This correlation does not 
differ for growing and for density-inhibited cells 
(fig.3). It seems reasonable to suppose that the size of 
puromycinyl-peptides is comparable in cultures, that 
have had their [ 3H]leucine incorporation inhibited to 
the same extent. Accordingly, fig.3 shows that com- 
parable, abnormal proteins are degraded equally fast 
in growing and in quiescent cells. 
The difference in degradation rates between puro- 
mycinylpeptides in growing and in density-inhibited 
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Fig.2. Effect of puromycin on [ SH]leucine incorporation into 
growing and quiescent Balb/3T3 cells. Growing and density- 
inhibited Balb/3T3 cultures in 5 cm Petri dishes were pre- 
pared as in [ 81. The cultures were incubated for 30 min in 
3 ml medium with the indicated concentration of puromycin. 
[ “H] Leucine was then added to fmal cont. 0.2 mM (10 &i/ 
ml), and the incubation continued for a further 30 min. The 
cultures were then washed in 3 X 6 ml PBS with 0.2 mM leu- 
tine and dissolved in 2 ml 0.1 M NaOH, 0.4% sodium deoxy- 
cholate. Incorporation was assessed from the trichloroacetic 
acid-insoluble radioactivity in this cell extract and calculated 
as % incorporation in the absence of puromycin. Open and 
filled symbols denote growing and density-inhibited cultures, 
respectively. 
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Fig.3. Correlation between inhibition of [ ‘HJleucine incorpo- 
ration by puromychr and subsequent release of [ ‘Hlleucine 
(protein degradation). Labelled Balb/3T3 cell cultures were 
prepared as in fe.2, whereupon they were washed by 3 X 6 ml 
PBS with 0.2 mM leucine and incubated in 5 ml growth 
medium with 10% (v/v) calf serum and 4 mM leucine. Protein 
degradation was assessed from the difference in trichloro- 
acetic acid-soluble radioactivity between samples of medium 
taken 10 min and 1 h after the end of the labelling period. 
Incorporation was calculated as the total recovered activity 
less the acid-soluble activity in the medium at the first sam- 
pling. Incorporation is expressed as % of the incorporation 
found in cultures with the same cell density, but without 
puromycin. Open and filled symbols denote growing and den- 
sity-inhibited cultures, respectively. 
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cells is therefore due to differences in the molecular 
weight of the puromycinyl-peptides, and there is no 
need to suggest a difference in the degradative appara- 
tus for abnormal proteins. 
A similar explanation may also hold for the obser- 
vations in [ 12,131 on differences in degradation rates 
between puromycinyl-peptides in growing and non- 
growing rat livers. The results therefore support the 
suggestion [S] that the majority of abnormal proteins 
follow a degradative pathway that is distinct from 
the pathway utilized for enhanced protein degradation. 
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